The Federal Perspective on Coverage of Medications to Treat Obesity: Considerations From the Congressional Budget Office
Presentation by Noelia Duchovny, an analyst in CBO’s Health Analysis Division, at the National Institute of Diabetes and Digestive and Kidney Diseases Workshop on GLP-1-Based Therapies.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
